{
    "clinical_study": {
        "@rank": "28565", 
        "arm_group": [
            {
                "arm_group_label": "JewelPump", 
                "arm_group_type": "Experimental", 
                "description": "JewelPump for the first treatment period followed by the usual pump for the second treatment period"
            }, 
            {
                "arm_group_label": "Usual insulin pump", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in the arm 2, will have the usual insulin pump for the first treatment period, followed with the second period which they will have the JewelPump."
            }
        ], 
        "brief_summary": {
            "textblock": "The study will be conducted, in cross-over with a time interval of at least 2 days between 2\n      treatment periods. Patients will be randomized into 2 groups According to the order of the\n      randomization, patients will bear the JewelPump for 5 days, followed by a period of 5 days\n      of treatment with their usual pumps."
        }, 
        "brief_title": "Feasibility Study of the JewelPump Version 3", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 1 Diabetes", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus, Type 1"
        }, 
        "detailed_description": {
            "textblock": "The JewelPump (Debiotech) will be compared to the conventional pumps. Patients will treated\n      with the JewelPump during 5 days, and with their usual pump during 5 other days.\n\n      The study will be conduct with 15 patients at the following investigation centers : Corbeil\n      Hospital, CHU of Strasbourg, and CHRU of Marseille."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients type 1 diabetics treated by external insulin pump;\n\n          -  Patients with HbA1c < 8.5%\n\n          -  Patients who signed consent\n\n        Exclusion Criteria:\n\n          -  Patients type 2 diabetics\n\n          -  Patients who have all serious diseases that could interfere with the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02097316", 
            "org_study_id": "2013-A00792-43"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "JewelPump", 
                    "Usual insulin pump"
                ], 
                "intervention_name": "JewelPump", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "JewelPump", 
                    "Usual insulin pump"
                ], 
                "intervention_name": "usual insulin pump", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Glycemic control", 
            "JewelPump accuracy"
        ], 
        "lastchanged_date": "March 24, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Sylvia FRANC, MD", 
                    "phone": "+33161697072"
                }, 
                "facility": {
                    "address": {
                        "city": "Evry", 
                        "country": "France", 
                        "zip": "91000"
                    }, 
                    "name": "Centre Hospitalier Sud Francilien"
                }, 
                "investigator": {
                    "last_name": "Sylvia FRANC, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "pauline.schaepelynck@ap-hm.fr", 
                    "last_name": "Pauline SCHAEPELYNCK, MD", 
                    "phone": "+334 91 74 55 00"
                }, 
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13000"
                    }, 
                    "name": "CHU Marseille-H\u00f4pital Nord"
                }, 
                "investigator": [
                    {
                        "last_name": "Denis RACCAH, Pr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Pauline SCAEPELYNCK, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67091"
                    }, 
                    "name": "CHU Strasbourg"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Feasibility Study of the JewelPump Version 3", 
        "other_outcome": [
            {
                "measure": "Time spent below 70 mg / dl", 
                "safety_issue": "Yes", 
                "time_frame": "up to 5 days in each treatment period"
            }, 
            {
                "measure": "Time spent above 180mg/dl;", 
                "safety_issue": "Yes", 
                "time_frame": "up to 5 days in each treatment period"
            }
        ], 
        "overall_contact": {
            "email": "pres@ceritd.fr", 
            "last_name": "Guillaume CHARPENTIER, MD", 
            "phone": "+33164968654"
        }, 
        "overall_official": [
            {
                "affiliation": "Centre Hospitalier Sud Francilien", 
                "last_name": "Sylvia FRANC, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Centre Hospitalier Universitaire de strasbourg", 
                "last_name": "Nathalie JEANDIDIER, Pr.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Centre Hospitalier Universitaire de Marseille", 
                "last_name": "Denis RACCAH, Pr.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Centre d\u2019Etudes et de Recherche pour l\u2019Intensification du Traitement du Diab\u00e8te", 
                "last_name": "Guillaume CHARPENTIER, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluate the non-inferiority of JewelPump compared to the usual pump patient, on glycemic control.", 
            "measure": "Time spent in glycemic area 70-180 mg / dl, measured continuously for 5 days with a continuous glucose monitoring (CGM) DEXCOM G4", 
            "safety_issue": "Yes", 
            "time_frame": "up to 5 days of each treatment period"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02097316"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Evaluate the superiority of JewelPump versus usual pump;", 
            "measure": "Time spent in the strict glycemic area 80-140 mg / dl", 
            "safety_issue": "Yes", 
            "time_frame": "up to 5 days of each treatment period"
        }, 
        "source": "Centre d\u2019Etudes et de Recherche pour l\u2019Intensification du Traitement du Diab\u00e8te", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre d\u2019Etudes et de Recherche pour l\u2019Intensification du Traitement du Diab\u00e8te", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}